1. Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Issue 10 (12th August 2022) Authors: Smit, Johan Willem; Basile, Peter; Prato, Maria Key; Detalle, Laurent; Mathy, François‐Xavier; Schmidt, Astrid; Lalla, Marianna; Germani, Massimiliano; Domange, Coralie; Biere, Anja‐Leona; Bani, Massimo; Carson, Stan; Genius, Just Journal: Movement disorders Issue: Volume 37:Issue 10(2022) Page Start: 2045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗